Introduction to Thymogen 20mg
Thymogen (also known as Thymagen) is a synthetic dipeptide bioregulator composed of L-glutamyl-L-tryptophan, commonly studied for its role in modulating immune activity in preclinical research. Originally derived from calf thymus extracts, Thymogen is now produced through synthetic and recombinant methods to ensure consistency and purity in laboratory studies. The 20mg dosage format supports reproducibility across experimental models.
Key Research Areas
Thymogen is under investigation in in vitro and in vivo settings for its effects on:
Immune Modulation Models: Studying thymic peptide interactions with lymphocyte activity, cytokine expression, and immune signaling.
Infectious Disease Research: Evaluating host immune responses to viral and bacterial exposure in controlled research environments.
Post-Surgical Recovery Models: Exploring recovery dynamics in animal models following induced trauma or surgical interventions.
Systemic Regulation Studies: Examining possible roles in metabolic and cardiovascular function regulation under stress-induced conditions.
For Laboratory Research Use Only – Not for Human or Veterinary Consumption
Thymogen 20mg is not approved by the FDA for therapeutic use. It is intended strictly for non-clinical, investigative applications in controlled research environments.
Certificate of Analysis
| Property | Description |
|---|---|
| Chemical Sequence | Glu-Trp |
| CAS | 38101-59-6 |
| Molecular Formula | C11H14N2O5 |
| Molecular Weight | Approximately 254.24 g/mol |
| Appearance | White Lyophilized Powder |
Research Use Only:
Thymogen 20mg is intended strictly for in vitro testing and laboratory experimentation. It is not intended for human or animal medical use. It is not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such
